SAN CARLOS, Calif.--(BUSINESS WIRE)--Jan. 5, 2006--Natus Medical Incorporated (Nasdaq:BABY) announced that it has completed today its acquisition of Bio-logic Systems Corp. Bio-logic formerly traded ...
The positive preliminary SENTI-202 clinical data was presented on April 27 in a Clinical Trials Oral Minisymposium at the American Association for Cancer Research (AACR) Annual Meeting 2025 in an ...
SAN FRANCISCO (MarketWatch) -- Bio-logic Systems Corp. said Wednesday its shareholders have approved the company's acquisition by Natus Medical Inc. for $8.77 a share, or $68 million. The merger is ...
AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced ...
Researchers at Rice University and the University of Kansas Medical Center are making genetic circuits that can perform more complex tasks by swapping protein building blocks. The modular genetic ...
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results